# Jacy Todd Continues GOP Bid After Cannabis-Related Conviction and Pardon Request > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabis-related-conviction-impact-nebraska-governor-bid/ > **Published:** 2026-04-24T11:09:56-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:12:37-04:00 > **Clinical Summary:** Explore the cannabis-related conviction impact on Nebraska's GOP governor bid and the ongoing legal and clinical implications for patients and providers. --- ✦ New CED Clinical Relevance #50 Clinical Context Background information relevant to the evolving [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) landscape. Policy Clinical Summary This article documents a political development involving a Republican gubernatorial candidate in Nebraska who has a cannabis-related conviction and is seeking a pardon while continuing to campaign for office. While primarily a political story, this illustrates the ongoing tension between criminal justice records related to cannabis and changing social attitudes toward the substance, which has direct implications for clinicians treating patients with cannabis use histories and for understanding the evolving legal landscape around cannabis access. The case demonstrates how cannabis-related convictions continue to affect individuals’ opportunities and civic participation, even as medical and recreational cannabis policies shift across different states. For clinicians, this underscores the importance of understanding that patients with historical cannabis convictions may face significant barriers to employment, housing, and other social determinants of health, which can impact their overall wellbeing and treatment engagement. Additionally, the normalization of cannabis policy discussion in mainstream political campaigns reflects broader shifts in public perception that may influence how patients approach conversations about cannabis use with their healthcare providers. Clinicians should remain informed about evolving cannabis policy at state and federal levels, as these changes directly influence their patients’ legal circumstances and access to cannabis as either a medical or recreational substance. Clinical Perspective While this article primarily concerns state politics rather than direct clinical evidence, the ongoing legal and political uncertainties surrounding cannabis policy at state and federal levels create practical challenges for healthcare providers navigating patient care. The fragmented regulatory landscape means clinicians may encounter patients using cannabis for various conditions while lacking clear, evidence-based prescribing frameworks and facing variable legal protections across jurisdictions. Such political volatility can complicate patient counseling on risks and benefits, medication interactions, and documentation practices, particularly in states where legalization status remains uncertain or subject to leadership changes. Clinicians should remain aware that cannabis policy will likely continue evolving through political channels rather than primarily through [clinical research](https://cedclinic.com/cannabis-based-therapies-smoking-cessation/), and should maintain clear, non-judgmental documentation of patient cannabis use while staying informed about their specific state’s current legal and regulatory status to provide consistent, informed guidance. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+Jacy+Todd+continues+GOP+bid+for+Nebraska+governor+after+conviction%2C+requests+pardon+%40drcaplan&url=https%3A%2F%2Fnebraskaexaminer.com%2F2026%2F03%2F02%2Fjacy-todd-continues-gop-bid-for-nebraska-governor-after-conviction-requests-pardon%2F)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fnebraskaexaminer.com%2F2026%2F03%2F02%2Fjacy-todd-continues-gop-bid-for-nebraska-governor-after-conviction-requests-pardon%2F)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+Jacy+Todd+continues+GOP+bid+for+Nebraska+governor+after+conviction%2C+requests+pardon+--+via+%40drcaplan.bsky.social+https%3A%2F%2Fnebraskaexaminer.com%2F2026%2F03%2F02%2Fjacy-todd-continues-gop-bid-for-nebraska-governor-after-conviction-requests-pardon%2F)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) Related Articles - Nebraska Medical Cannabis Regulations Advance to State Leaders – Lincoln Today - [CED Digest: 239 Items — March 17, 2026](https://cedclinic.com/cannabis-clinical-digest-march-17-2026/) - [CED Digest: 436 Items — March 14, 2026](https://cedclinic.com/cannabis-compounds-fatty-liver-disease-2026/) 📰 Source: [https://nebraskaexaminer.com/2026/03/02/jacy-todd-continues-gop-bid-for-nebraska-governor-after-conviction-requests-pardon/](https://nebraskaexaminer.com/2026/03/02/jacy-todd-continues-gop-bid-for-nebraska-governor-after-conviction-requests-pardon/) Further Reading CED Clinic Blog[Cannabinoids and Chronic Pain: 2025 Evidence Review](https://cedclinic.com/cannabinoids-chronic-pain-clinical-outcomes-2025/) Cannabis Policy WireCED Regulatory Digest, Since Last Digest, 1 items Evidence Watch[Neuropathic Pain Severity Is Associated With Opioid Use in Adults With Traumatic Spinal Cord Injury: A Spinal Cord Injury Model System Study.](https://cedclinic.com/opioid-use-neuropathic-pain-spinal-cord-injury/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Justice Department, DEA ordered to reclassify state-licensed medical cannabis as less … – Maui Now](https://cedclinic.com/federal-cannabis-reclassification-clinical-implications/) Explore federal cannabis reclassification and its clinical impact on patients and providers. [Read More](https://cedclinic.com/federal-cannabis-reclassification-clinical-implications/) [Why the future of marijuana legalization remains hazy despite high public support](https://cedclinic.com/cannabis-legalization-implementation-challenges-patient-access/) Understand the challenges in marijuana legalization and patient access despite widespread support. [Learn More](https://cedclinic.com/cannabis-legalization-implementation-challenges-patient-access/) [Federal Rescheduling Reshapes Industry as Markets and States Recalibrate – Business of Cannabis](https://cedclinic.com/cannabis-federal-rescheduling-clinical-implications/) Discover how federal cannabis rescheduling affects industry and clinical practices. [Explore Now](https://cedclinic.com/cannabis-federal-rescheduling-clinical-implications/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).